Carlos Bagley

Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA.

Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO.

VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD.

PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas.

Parkland Health & Hospital System Auxiliary owns and operates hospitals. It offers medical services and health care services to patients related to trauma, burns, strokes, cancer, women and infant health, epilepsy, cardiology, orthopedics, and geriatric care. The company was founded May 19, 1894 and is headquartered in Dallas, TX.

Carnegie Institution of Washington is engaged in providing technical and scientific research services. The company was founded by Andrew Carnegie in 1895 and is headquartered in Washington, DC.

Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA.

The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

The American College of Surgeons Oncology Group (ACOSOG) was established to evaluate the surgical management of patients with malignant solid tumors. ACOSOG is one of 10 cooperative groups funded by the National Cancer Institute (NCI) to develop and coordinate multi-institutional clinical trials. ACOSOG is the only cooperative group with studies focusing primarily on surgical objectives. ACOSOG currently has treatment protocols available in three major disease areas: . Breast Cancer . Gastrointestinal Cancer . Thoracic Cancer ACOSOG is composed of the Operations and Membership Center located at the Duke Clinical Research Institute on the Duke University Medical Center campus and the Statistics and Data Center located at the Mayo Clinic Cancer Center. ACOSOG's membership is comprised of investigators and research associates representing oncology treatment modalities and research-related concerns, including surgery, medical oncology, radiation oncology, diagnostic imaging, pathology, ethics, CRA/nursing and patient advocacy.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco.

American Gastroenterological Association engages in the science and practice of gastroenterology. The private company is based in Bethesda, MD.

The Gi Company Inc. develops drugs to treat gastrointestinal and related diseases. It offers intestinal trefoil factor for the treatment of oral mucositis. The company also has projects in enteritis, proctitis, inflammatory bowel disease, erosive gastro esophageal reflux disease, peptic ulcer disease and gastrointestinal motility disorders, as well as clinical programs in erosive gastritis, ulcerative colitis and corneal wound healing. The company was founded in 1998 and is headquartered in Framingham, MA.

Advanced Facial Plastic Surgery Center PA offers reconstructive and age defying facial cosmetic procedure. Its procedures include facelift, nasal surgery, fractionated CO2 laser resurfacing, minilift. The company was founded in 2003 and is headquartered in Dallas, TX.

Dallas Zoological Society engages in saving wildlife. The company was founded in 1888 and is headquartered in Dallas, TX.

The North Texas Commission is a public-private partnership that manages the region's unified advocacy voice at the state and federal levels. The private company is based in Irving, TX. The commission is dedicated to advancing the vibrancy of the region and achieves impactful outcomes benefiting the 13-county area it serves. As the lead convener of subject matter experts, the NTC improves the workforce pipeline and cultivates future leaders. The CEO of the company is Chris Wallace.

Employer Direct Healthcare, LLC provides healthcare solutions for self-funded employers in the United States. It allows plan members to access a network of medical providers and facilities for various procedures, such as major heart, orthopedic, spine, colonoscopy and endoscopy, and outpatient procedures. The company offers a capacity-management tool for healthcare providers to manage patient flows. The company was founded by Robert Kummer and Erickson Ken in 2010 and is headquartered in Dallas, TX.

Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA.

Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA.

Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022.

Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan.

Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023.